Both epidemiological and biochemistry studies documented a carcinogenic role of pheomelanins produced by functionally impaired receptor encoded by some MC1R allelic variants, considered as disruptive [15]: suspected underlying mechanisms included increased oxidative stress, inflammation, and immunomodulation [13], resulting in low to moderate melanoma risk [16]. Here, MC1R is linked to melanoma.